Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart

Details for Australian Patent Application No. 2008347450 (hide)

Owner Philogen S.p.A.

Inventors Menssen, Hans Dietrich; Menrad, Andreas; Neri, Dario; Schliemann, Christoph

Agent Fisher Adams Kelly

Pub. Number AU-A-2008347450

PCT Pub. Number WO2009/089858

Priority 08075044.1 17.01.08 EP

Filing date 8 November 2008

Wipo publication date 23 July 2009

International Classifications

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 39/44 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies bound to carriers

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

5 August 2010 PCT application entered the National Phase

  PCT publication WO2009/089858 Priority application(s): WO2009/089858

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008347483-A keyboard with a plurality of sensitive key elements

2008347438-Methods for increasing the therapeutic efficacy of immunoglobulin G class 3 (IgG3) antibodies